Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
GSK's blood cancer drug gets EU approval for multiple myeloma
12:27pm, Thursday, 24'th Jul 2025
British drugmaker GSK said on Thursday the European Union has approved the company's blood cancer drug Blenrep for the treatment of relapsed or refractory multiple myeloma.
GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults
09:00am, Thursday, 24'th Jul 2025
PHILADELPHIA--(BUSINESS WIRE)-- #Adult--GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults.
US FDA extends review of GSK's blood cancer drug
12:15pm, Wednesday, 23'rd Jul 2025
The U.S. Food and Drug Administration has extended its review of GSK's blood cancer drug Blenrep as a combination treatment, the company said on Wednesday.
GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth
11:08am, Wednesday, 23'rd Jul 2025
Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GSK plc – GSK
10:00am, Wednesday, 23'rd Jul 2025
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of GSK plc (“GSK” or the “Company”) (NYSE: GSK). Such investors are advised to contac
FDA Advisory Panel Votes Against Approval of GSK's Blenrep Combo
11:41am, Friday, 18'th Jul 2025
GSK stock falls as an FDA panel votes against its Blenrep combo, casting doubt on U.S. approval hopes.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:50am, Friday, 18'th Jul 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
GSK Shares Drop After FDA Committee Vote Leaves Cancer-Drug Comeback in Doubt
08:44am, Friday, 18'th Jul 2025
The pharmaceutical company said it remained confident in the benefit and risk profile of Blenrep and will continue to work with the FDA.
GSK shares analysts get out the red pens after FDA knock-back wipes £3bn from drug maker's value
08:38am, Friday, 18'th Jul 2025
Shares in GSK PLC (LSE:GSK, NYSE:GSK) fell 6% on Thursday, wiping more than £3bn from its market value, after a US advisory committee delivered a serious blow to the drugmaker's oncology ambitions.
GSK shares slide 6% after US panel rejects key cancer drug combination
05:16am, Friday, 18'th Jul 2025
GSK PLC (LSE:GSK, NYSE:GSK) shares dropped 6% on Friday, erasing over £3 billion from its market value, after a panel of experts advising the US Food and Drug Administration voted against the compan
GSK shares fall after blood cancer drug likely headed for U.S. rejection
03:24am, Friday, 18'th Jul 2025
GSK shares fell more than 6% on Friday after a U.S. FDA advisory panel recommended against approving its blood cancer drug Blenrep, citing earlier concerns over eye-related side effects.
GSK gets red light from FDA cancer committee on Blenrep combos
02:49am, Friday, 18'th Jul 2025
An expert panel advising the US drug regulator has voted against GSK PLC's (LSE:GSK, NYSE:GSK) Blenrep drug combinations for patients with relapsed or refractory multiple myeloma. The US Food and Dr
FDA Committee Votes Against GSK Blood Cancer Drug Blenrep
06:19pm, Thursday, 17'th Jul 2025
The British pharmaceutical company said combinations for its Blenrep drug were evaluated in adults with relapsed or refractory multiple myeloma who have previously received at least one line of therap
Despite new market entrants in the form of Gilead's Livdelzi and Ipsen's Iqirvo, US gastroenterologists report nearly half of PBC patients suffer from moderate to severe pruritus, underscoring an exis
FDA advisers vote against combination therapies of GSK's blood cancer drug
12:53pm, Thursday, 17'th Jul 2025
The U.S. Food and Drug Administration's panel of independent advisers voted on Thursday against approval of GSK's blood cancer drug Blenrep for use in combination with other treatments.
